STAT5 has previously been associated with sex differences in liver metabolism (27) and pulmonary hypertension (28), both with a proposed neuroendocrine regulation through hypothalamus-growth hormone-STAT5 axis. This evidence concerns the gene GH1 and pulmonary arterial hypertension.